The stock has a 36-month beta value of -0.08. Opinions on the stock are mixed, with 0 analysts rating it as a “buy”, 1 as “overweight”, 0 as “hold”, and 0 as “sell”.
The public float for REVB is 0.68M, and at present, short sellers hold a 7.53% of that float. On July 08, 2025, the average trading volume of REVB was 364.96K shares.
REVB stock’s latest price update
Revelation Biosciences Inc (NASDAQ: REVB)’s stock price has soared by 13.14% in relation to previous closing price of $2.28. Nevertheless, the company has seen a gain of 13.29% in its stock price over the last five trading days. businesswire.com reported 2025-07-01 that SAN DIEGO–(BUSINESS WIRE)—- $REVB #AKI–Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, on July 7, 2025, the Company will implement a 1-for-3 reverse split of its common stock following approval at its Special Meeting of Stockholders held on June 23, 2025. The reverse stock split will be effective as of the morning of July 7, 2025, and the Company’s common stock will trade on a post-split basis at the beginning of trading on the same date under the existin.
REVB’s Market Performance
Revelation Biosciences Inc (REVB) has seen a 13.29% rise in stock performance for the week, with a -2.77% decline in the past month and a -69.40% plunge in the past quarter. The volatility ratio for the week is 12.06%, and the volatility levels for the past 30 days are at 9.21% for REVB. The simple moving average for the past 20 days is 6.50% for REVB’s stock, with a -86.36% simple moving average for the past 200 days.
REVB Trading at -52.24% from the 50-Day Moving Average
After a stumble in the market that brought REVB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.46% of loss for the given period.
Volatility was left at 9.21%, however, over the last 30 days, the volatility rate increased by 12.06%, as shares surge +5.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -69.88% lower at present.
During the last 5 trading sessions, REVB rose by +13.29%, which changed the moving average for the period of 200-days by -94.02% in comparison to the 20-day moving average, which settled at $2.4200. In addition, Revelation Biosciences Inc saw -97.00% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
N/A, the N/A of Revelation Biosciences Inc, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for REVB
The total capital return value is set at -2.84%. Equity return is now at value -233.26%, with -154.33% for asset returns.
Currently, EBITDA for the company is -7.95 million with net debt to EBITDA at 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.61.
Conclusion
To sum up, Revelation Biosciences Inc (REVB) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
